Group One Trading’s Immune Design Corp. IMDZ Stock Holding History

Group One Trading’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-17,594	Closed	-$70.1K	–	5857
2018 Q1	$58K	Sell	17,594 -500	-3%	-$1.77K	﹤0.01%	3589
2017 Q4	$71K	Buy	+18,094	New	+$98.5K	﹤0.01%	3550
2017 Q2	–	Sell	-2,500	Closed	-$17K	–	5512
2017 Q1	$17K	Sell	2,500 -1,500	-38%	-$8.67K	﹤0.01%	3946
2016 Q4	$22K	Buy	+4,000	New	+$28.3K	﹤0.01%	3676
2016 Q2	–	Sell	-617	Closed	-$8K	–	5365
2016 Q1	$8K	Sell	617 -100	-14%	-$1.16K	﹤0.01%	4109
2015 Q4	$14K	Sell	717 -1,300	-64%	-$22.4K	﹤0.01%	4082
2015 Q3	$25K	Buy	+2,017	New	+$37.8K	﹤0.01%	3944

Group One Trading's IMDZ Position: Q2 2018 in Review

Group One Trading sold out of Immune Design Corp. (IMDZ) in Q2 2018, closing a stake of 17,594 shares — an estimated $70.1K sold.

Group One Trading first reported a position in IMDZ in Q3 2015 and held it in 7 quarters. The position peaked at $71K in Q4 2017. 80 funds tracked by Wall St. Rank hold IMDZ as of Q2 2018.

Group One Trading reported no remaining Immune Design Corp. position as of Q2 2018 after selling out during the quarter.
Group One Trading sold 17,594 Immune Design Corp. shares in Q2 2018, an estimated $70.1K.
Group One Trading first reported a position in Immune Design Corp. in Q3 2015 and held it in 7 quarters.
Group One Trading's Immune Design Corp. position peaked at $71K in Q4 2017.
80 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2018.

Based on Group One Trading's 13F filing for Q2 2018, filed 14 Aug 2018.